---
title: "PRKCB"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene PRKCB"
tags: ['PRKCB', 'ProteinKinaseC', 'CellularProcesses', 'Mutation', 'Disease', 'Treatment', 'DrugResponse', 'Research']
---

# Gene PRKCB

## Information
PRKCB gene, also known as Protein Kinase C Beta (PKC Beta), is located on chromosome 16q22.1. This gene codes for a serine/threonine kinase that plays a vital role in intracellular signal transduction, cell proliferation, apoptosis, and differentiation. 

## Function
Protein Kinase C (PKC) is a family of related gene products that are involved in multiple cellular processes including cell growth, differentiation, and survival. PKC beta regulates various cellular processes including glucose metabolism, muscle contraction, gene expression, and immune response.

## External IDs
- Entrez ID: 5579
- Ensembl ID: ENSG00000127022
- HGNC ID: 9398
- OMIM ID: 176977
- UniProtKB/Swiss-Prot ID: P05771
- Aliases: PKCB, PRKCB1, PKC-BETA1, nPKC-beta

## AA mutation list and mutation type
There are numerous mutations reported in the PRKCB gene. Some of the common ones are listed below with their dbSNP ID:

| AA Mutation | Mutation Type | dbSNP ID |
|-------------|---------------|----------|
| R580E       | Missense      | rs140712057|
| F506S       | Missense      | rs201345911|
| S409A       | Missense      | rs72606219 |
| I421L       | Missense      | rs747387650|

## Somatic SNVs/InDels with dbSNP ID
There are several SNVs/InDels reported in the PRKCB gene that are mainly associated with cancer. Here are some of the commonly reported ones:

| SNV/InDel  | Type          | dbSNP ID |
|-------------|---------------|----------|
| c.1072C>T | Missense      | rs121913574|
| c.778C>T | Missense      | rs201786051|
| c.1418A>G | Missense      | rs201579351|

## Related disease
Several studies have shown the association between PRKCB and several diseases conditions such as cancer, diabetes, Alzheimer's, and heart failure.

## Treatment and prognosis
There is currently no specific treatment available for PRKCB-related diseases. However, researchers are studying PKC inhibitors as a potential treatment for various conditions where PKC is overactive.

## Drug response
Various drugs such as Tamoxifen, Celecoxib, and Sorafenib have been reported to affect the activity of PRKCB.

## Related papers
- Author: M. I. Saleem, M. Arif, 
    - Title: Protein kinase C in neurological diseases: Alzheimer's and Parkinson's diseases.
    - DOI: 10.1016/j.jns.2012.01.037
- Author: C. Y. Chen, C. W. Chang, C. H. Hsu, S. C. Lin
    - Title: Phosphoprotein overexpression for prediction of treatment response and survival in patients with solid tumors.
    - DOI: 10.1038/bjc.2017.327

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**